Dr. Margarita Mersiyanova
Senior Industry Consultant, Global Health & Life Sciences Customer Advisory
Dr. Margarita Mersiyanova is a Senior Industry Consultant within the Global Health and Life Sciences Customer Advisory practice, based in London. She specializes in guiding life sciences and healthcare organizations through complex digital transformations by leveraging advanced analytics, artificial intelligence, and technology.
Her work focuses on addressing critical industry challenges, such as navigating trustworthy AI adoption in clinical trials, optimizing trial protocols with real-world evidence, and exploring the use of synthetic data to accelerate drug development while maintaining strict regulatory compliance.
Prior to her current role at SAS, Dr. Mersiyanova served as a Senior Scientist at Pfizer, where she developed deep expertise in pharmaceutical research and development. She holds a Doctoral degree in Analytical Chemistry and a Master’s degree in Pharmaceutics, both from University College London (UCL). Her academic background includes published scientific research on high-affinity molecularly imprinted polymers (MIPs) and peptide sequence analysis.
A recognized thought leader, Dr. Mersiyanova frequently shares her insights as an author for SAS Blogs and a speaker at major industry conferences, including BioTechX Europe and SAS Innovate. Through her unique blend of scientific and technological expertise, she champions the use of explainable AI to reshape the future of global healthcare.
Featured Presentations
Margarita helps organizations unlock the power of analytics to drive real business transformation. With clear insights and practical strategies, she shows teams how to turn data into action and accelerate meaningful change.